SALT
LAKE CITY, May 23, 2022 /PRNewswire/ --
PolarityTE, Inc. (Nasdaq: PTE) today announced that
Richard Hague, Chief Executive
Officer, and Nikolai Sopko, MD, PhD,
Chief Scientific Officer, will present at the upcoming H.C.
Wainwright Global Investment Conference, being held May 23-26, 2022, in Miami and virtually.
The on-demand session of Mr. Hague and Dr. Sopko's presentation
will be available on May 24, 2022 at
7:00am Eastern Time.
For more information, visit:
https://hcwevents.com/globalconference/
About PolarityTE®
PolarityTE, Inc., headquartered in
Salt Lake City, Utah, is a
biotechnology company developing regenerative tissue
products. PolarityTE's first regenerative tissue product is
SkinTE®. PolarityTE has an open investigational new drug
application (IND) for SkinTE® with the U.S. Food and Drug
Administration (FDA) and is now pursuing the first of two pivotal
studies on SkinTE® needed to support a biologics license
application (BLA) for a chronic cutaneous ulcer indication.
SkinTE® is available for investigational use only. Learn more at
www.PolarityTE.com.
Forward Looking Statements
Certain statements
contained in this release are "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of
1995. They are generally identified by words such as "believes,"
"may," "expects," "anticipates," "intend," "plan," "will," "would,"
"should" and similar expressions. Readers should not place undue
reliance on such forward-looking statements, which are based upon
the Company's beliefs and assumptions as of the date of this
release. The Company's actual results could differ materially due
to the impact of the COVID-19 pandemic, future clinical studies,
and FDA regulatory matters, which cannot be predicted, and the risk
factors and other items described in more detail in the "Risk
Factors" section of the Company's Annual Reports and other filings
with the SEC (copies of which may be obtained at www.sec.gov).
Subsequent events and developments may cause these forward-looking
statements to change. The Company specifically disclaims any
obligation or intention to update or revise these forward-looking
statements as a result of changed events or circumstances that
occur after the date of this release, except as required by
applicable law.
POLARITYTE, the POLARITYTE logo, SKINTE, WHERE SELF REGENERATES
SELF and WELCOME TO THE SHIFT are registered trademarks of
PolarityTE, Inc.
CONTACTS
Investors:
PolarityTE Investor Relations
ir@PolarityTE.com
(385) 831-5284
Media:
David Schull or
Ignacio Guerrero-Ros
David.schull@russopartnersllc.com
Ignacio.guerrero-ros@russopartnersllc.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/polarityte-to-attend-hc-wainwright-global-investment-conference-301552547.html
SOURCE PolarityTE, Inc.